Skip to main content

Inhibitor Therapeutics, Inc.

INTI
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001042418

No open-market purchases or sales by Inhibitor Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding INTI, Q2 2026

See all superinvestors

No superinvestor reported holding INTI in Q2 2026.